{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:48:45Z","timestamp":1790092125628,"version":"4.0.1"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Piperacillin\u2013tazobactam is a widely used antibiotic. Although rare, thrombocytopenia related to piperacillin\u2013tazobactam can be clinically significant. Drug-induced immune thrombocytopenia (DIIT) is difficult to distinguish from thrombocytopenia related to critical illness, infection, disseminated intravascular coagulation (DIC), or heparin-induced thrombocytopenia (HIT). We report a case of piperacillin\u2013tazobactam-associated thrombocytopenia and review the literature to emphasize that negative antiplatelet antibody testing does not exclude this diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We report a 57-year-old woman with severe trauma and pulmonary infection who developed abrupt, severe thrombocytopenia after initiating piperacillin\u2013tazobactam. The platelet count recovered rapidly after piperacillin\u2013tazobactam was withdrawn. Coagulation parameters did not support overt DIC as the primary cause, and HIT was considered unlikely (4Ts score \u22643; no thrombosis on serial bedside ultrasonography). A Naranjo Adverse Drug Reaction Probability Scale score of 5 indicated a probable adverse drug reaction. Flow cytometric testing for anti-platelet antibodies was negative.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Review<\/jats:title>\n                    <jats:p>We identified 23 eligible reports. All patients were considered immune-mediated. Antiplatelet antibody testing was not performed on many patients; importantly, piperacillin\u2013tazobactam-associated immune thrombocytopenia has also been suspected in cases with negative antibody results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case and the reviewed literature highlight that negative platelet antibody testing does not exclude piperacillin\u2013tazobactam-associated DIIT. A structured diagnostic approach and close platelet monitoring are warranted when DIIT is suspected in critically ill patients. Clinical evaluation and temporal association remain critical for diagnosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1775491","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T05:35:20Z","timestamp":1773207320000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Piperacillin\u2013tazobactam-associated thrombocytopenia with negative antiplatelet antibody testing: a case report and literature review"],"prefix":"10.3389","volume":"13","author":[{"given":"Pengcheng","family":"Tian","sequence":"first","affiliation":[{"name":"Wuhan Jinyintan Hospital, Tongji Medical College of Huazhong University of Science and Technology","place":["Wuhan, China"]},{"name":"Hubei Clinical Research Center for Infectious Diseases","place":["Wuhan, China"]},{"name":"Wuhan Research Center for Communicable Disease Diagnosis and Treatment, Chinese Academy of Medical Sciences","place":["Wuhan, China"]},{"name":"Joint Laboratory of Infectious Diseases and Health, Wuhan Institute of Virology and Wuhan Jinyintan Hospital, Chinese Academy of Sciences","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Fan","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaolin","family":"Huang","sequence":"additional","affiliation":[{"name":"Wuhan Jinyintan Hospital, Tongji Medical College of Huazhong University of Science and Technology","place":["Wuhan, China"]},{"name":"Hubei Clinical Research Center for Infectious Diseases","place":["Wuhan, China"]},{"name":"Wuhan Research Center for Communicable Disease Diagnosis and Treatment, Chinese Academy of Medical Sciences","place":["Wuhan, China"]},{"name":"Joint Laboratory of Infectious Diseases and Health, Wuhan Institute of Virology and Wuhan Jinyintan Hospital, Chinese Academy of Sciences","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.2165\/00019053-200119110-00006","article-title":"Piperacillin\/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections","volume":"19","author":"Young","year":"2001","journal-title":"Pharmacoeconomics"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1177\/10915818211048151","article-title":"Evaluation of the expression profile of antibiotic-induced thrombocytopenia using the Japanese adverse drug event report database","volume":"40","author":"Asai","year":"2021","journal-title":"Int J Toxicol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1586\/14787210.5.3.365","article-title":"Piperacillin-tazobactam: a beta-lactam\/beta-lactamase inhibitor combination","volume":"5","author":"Gin","year":"2007","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11101384","article-title":"Pragmatic comparison of piperacillin\/tazobactam versus carbapenems in treating patients with nosocomial pneumonia caused by extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae","volume":"11","author":"Zha","year":"2022","journal-title":"Antibiotics"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"805","DOI":"10.2165\/00003495-199957050-00017","article-title":"Piperacillin\/tazobactam: an updated review of its use in the treatment of bacterial infections","volume":"57","author":"Perry","year":"1999","journal-title":"Drugs"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1681\/asn.2018121223","article-title":"Piperacillin\/tazobactam and antibiotic-associated acute kidney injury in critically ill children","volume":"30","author":"Joyce","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3892\/etm.2016.3062","article-title":"Tazobactam and piperacillin-induced thrombocytopenia: a case report","volume":"11","author":"Chen","year":"2016","journal-title":"Exp Ther Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","article-title":"International consensus report on the investigation and management of primary immune thrombocytopenia","volume":"115","author":"Provan","year":"2010","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s12519-022-00650-1","article-title":"Safety and clinical efficacy of linezolid in children: a systematic review and meta-analysis","volume":"19","author":"Shi","year":"2023","journal-title":"World J Pediatr"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e26970","DOI":"10.7759\/cureus.26970","article-title":"Piperacillin-Tazobactam induced rapid severe thrombocytopenia without known exposure","volume":"14","author":"Bhaskarla","year":"2022","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9072212","article-title":"Pathophysiology and diagnosis of drug-induced immune thrombocytopenia","volume":"9","author":"Vayne","year":"2020","journal-title":"J Clin Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s150100050042","article-title":"Leukocytopenia, thrombocytopenia and fever related to piperacillin\/tazobactam treatment--a retrospective analysis in 38 children with cystic fibrosis","volume":"27","author":"Reichardt","year":"1999","journal-title":"Infection"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3109\/09537104.2010.549973","article-title":"Piperacillin and vancomycin induced severe thrombocytopenia in a hospitalized patient","volume":"22","author":"Anand","year":"2011","journal-title":"Platelets"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ijantimicag.2016.11.018","article-title":"A propensity score-matched analysis of the impact of minimum inhibitory concentration on mortality in patients with Pseudomonas aeruginosa bacteraemia treated with piperacillin\/tazobactam","volume":"49","author":"Gentry","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e81477","DOI":"10.1371\/journal.pone.0081477","article-title":"The potential of antimicrobials to induce thrombocytopenia in critically ill patients: data from a randomized controlled trial","volume":"8","author":"Johansen","year":"2013","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3109\/00365548.2013.805426","article-title":"Severe bone marrow suppression and hepatic dysfunction caused by piperacillin\/tazobactam","volume":"45","author":"He","year":"2013","journal-title":"Scand J Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e18000","DOI":"10.7759\/cureus.18000","article-title":"A rare case of rapid onset thrombocytopenia induced by piperacillin\/tazobactam in a liver transplant recipient","volume":"13","author":"Al-Sardi","year":"2021","journal-title":"Cureus"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1136\/ejhpharm-2020-002575","article-title":"An unusual case of piperacillin-tazobactam-induced fever, eosinophilia, thrombocytopenia and liver damage","volume":"29","author":"Lv","year":"2022","journal-title":"Eur J Hosp Pharm"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e320","DOI":"10.1111\/bjh.16899","article-title":"Piperacillin-dependent anti-platelet antibodies are a relevant, easy to confirm differential diagnosis in patients with rapid-onset thrombocytopenia","volume":"190","author":"Chen","year":"2020","journal-title":"Br J Haematol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-232944","article-title":"Piperacillin-tazobactam induced bicytopenia in low cumulative treatment doses","volume":"12","author":"Chen","year":"2019","journal-title":"BMJ Case Rep"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s11239-019-01848-3","article-title":"Cefepime challenge after piperacillin\/tazobactam-induced thrombocytopenia","volume":"48","author":"Beaulieu","year":"2019","journal-title":"J Thromb Thrombolysis"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1080\/09537104.2018.1468025","article-title":"Rapid onset severe thrombocytopenia following reexposure to piperacillin-tazobactam: report of two cases and review of the literature","volume":"29","author":"Alzahrani","year":"2018","journal-title":"Platelets"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/j.transproceed.2017.02.043","article-title":"Piperacillin-induced thrombocytopenia in a dual heart and kidney transplant patient: a case report","volume":"49","author":"Patel","year":"2017","journal-title":"Transplant Proc"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/jcpt.12458","article-title":"Piperacillin\/tazobactam-induced immune-mediated thrombocytopenia in the intensive care unit","volume":"41","author":"Boyce","year":"2016","journal-title":"J Clin Pharm Ther"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e326","DOI":"10.1002\/phar.1675","article-title":"Rapid-onset thrombocytopenia following piperacillin-tazobactam reexposure","volume":"35","author":"Nguyen","year":"2015","journal-title":"Pharmacotherapy"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.jclinane.2015.06.021","article-title":"Drug-induced immune-mediated thrombocytopenia in the intensive care unit","volume":"27","author":"Bose","year":"2015","journal-title":"J Clin Anesth"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3109\/03009734.2013.838811","article-title":"Alternative diagnosis to heparin-induced thrombocytopenia in two critically ill patients despite a positive PF4\/heparin-antibody test","volume":"118","author":"Hron","year":"2013","journal-title":"Ups J Med Sci"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3109\/00365548.2012.697638","article-title":"Piperacillin\/tazobactam-induced neutropenia, thrombocytopenia, and fever during treatment of a diabetic foot infection","volume":"45","author":"Uzun","year":"2013","journal-title":"Scand J Infect Dis"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1111\/j.1542-4758.2012.00745.x","article-title":"Piperacillin-induced thrombocytopenia reversed by high-flux hemodialysis in an uremic patient","volume":"16","author":"Lin","year":"2012","journal-title":"Hemodial Int"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/ajh.21536","article-title":"Recurrent acute thrombocytopenia in the hospitalized patient: sepsis, DIC, HIT, or antibiotic-induced thrombocytopenia","volume":"85","author":"Rousan","year":"2010","journal-title":"Am J Hematol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"3000605231162434","DOI":"10.1177\/03000605231162434","article-title":"Cross-reactivity between piperacillin-tazobactam and cefoperazone-sulbactam in drug-induced immune thrombocytopenia","volume":"51","author":"He","year":"2023","journal-title":"J Int Med Res"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1089\/sur.2022.169","article-title":"Letter to the editor: thrombocytopenia caused by vancomycin and piperacillin-tazobactam after ascending aorta replacement","volume":"23","author":"He","year":"2022","journal-title":"Surg Infect"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s002770000195","article-title":"Thrombotic thrombocytopenia purpura caused by piperacillin successfully treated with plasma infusion","volume":"79","author":"Yata","year":"2000","journal-title":"Ann Hematol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1775491\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T05:35:21Z","timestamp":1773207321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1775491\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":33,"alternative-id":["10.3389\/fmed.2026.1775491"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1775491","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"article-number":"1775491"}}